Jennifer Levine
Otolaryngology/Facial Plastic Surgery New York, NY Medical Doctor
NPI 1821157751 CMS profile 37788
240 E 79Th St, New York, NY 10075
General payments
$454,082
Research payments
$15,885
Ownership & investment interest
$0
Research they led as principal investigator
$193,835
Through program year 2025, Jennifer Levine of New York, NY is reported in the CMS Open Payments database as having received $454,082 across 654 general payments and $15,885 in research payments paid to them. Separately, studies naming them as principal investigator received $193,835 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 99th percentile of Otolaryngology/Facial Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
8 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $82,895 | 102 | |
| 2024 | General | $88,230 | 93 | |
| 2023 | General | $71,528 | 111 | |
| 2022 | General | $43,071 | 88 | |
| 2022 | Research | $15,885 | 1 | |
| 2021 | General | $46,827 | 93 | |
| 2020 | General | $62,993 | 55 | |
| 2019 | General | $58,538 | 112 |
Beside peers
- Jennifer Levine
- Otolaryngology/Facial Plastic Surgery median
- Middle half of Otolaryngology/Facial Plastic Surgery
- National median
In program year 2025, general payments to Jennifer Levine were reported at $82,895. Among 526 Otolaryngology/Facial Plastic Surgery profiles paid that year, the median was $306 and the middle half received between $100 and $757.
Show as a table
| Year | Jennifer Levine | Otolaryngology/Facial Plastic Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $58,538 | $237 | $98–$548 | $163 |
| 2020 | $62,993 | $118 | $46–$265 | $114 |
| 2021 | $46,827 | $179 | $69–$469 | $132 |
| 2022 | $43,071 | $212 | $94–$520 | $149 |
| 2023 | $71,528 | $225 | $97–$552 | $160 |
| 2024 | $88,230 | $285 | $111–$707 | $164 |
| 2025 | $82,895 | $306 | $100–$757 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
655 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Otolaryngology/Facial Plastic Surgery in New York
Jason Moche
Otolaryngology/Facial Plastic Surgery · New York, NY
Stephen Warman
Otolaryngology/Facial Plastic Surgery · Forest Hills, NY
Stacey Silvers
Otolaryngology/Facial Plastic Surgery · New York, NY
Dara Liotta
Otolaryngology/Facial Plastic Surgery · New York, NY
Amar Suryadevara
Otolaryngology/Facial Plastic Surgery · Syracuse, NY
Sean Kennedy
Otolaryngology/Facial Plastic Surgery · Glens Falls, NY
Related records
Otolaryngology/Facial Plastic Surgery in New York
Practitioners in the same specialty and state, ranked by reported value.
All Otolaryngology/Facial Plastic Surgery
Everyone recorded under this specialty, nationwide.
Doctors in New York
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.